Methylphenidate in ADHD Preschoolers with Disability
The safety and efficacy of methylphenidate (MPH), 0.3 and 0.6 mg/kg, in 11 preschool children (aged 4-5 years) with developmental disabilities and attention deficit hyperactivity disorder (ADHD) were determined in a double-blind, placebo-controlled, crossover study at the Western Psychiatric Institu...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1999-07-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/2086 |